An obesity drug from China helped patients lose a lot of weight in a late-stage clinical trial, making it a prospective new ...

Overweight patients given an experimental weight loss drug being developed by China's Sciwind Biosciences lost an average of ...

New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...

The immensely successful new age weight loss jabs have finally come to India with the recent launch of Eli Lilly’s Mounjaro ... abundantly clear that the benefits of these drugs go way beyond ...

Novo Nordisk is banking on fresh leadership to help it reclaim the crown in the booming weight loss drug market. The Danish drugmaker on Friday abruptly announced that longtime CEO Lars Fruergaard ...

Novo Nordisk is banking on fresh leadership to help it reclaim the crown in the booming weight loss drug market. Stream NBC 5 for free, 24/7, wherever you are. The Danish drugmaker on Friday ...

The global market for diabetes drugs used for treating obesity is expected to expand in Asia, as new players jostle with giants Eli Lilly and ... The market for weight-loss drugs could see new ...

Eli Lilly’s weight loss drug Zepbound outperformed competitor ... “This represents a clear conflict of interest, which is common in these head-to-head studies, and is always good to keep ...